I found that so many people were making their own GLP-1s and taking smaller amounts than normally prescribed,” she said. “I ...

Life expectancy in the U.S. last year made an unusually sharp increase as deaths from most major causes declined, according to the ...

The truth is that the administration’s “harm reduction” policies — such as distributing sterile needles and opioid ... GLP-1 medicines such as Ozempic could help extend lifespans by ...

Life expectancy in 2023 rose 0.9 years to 78.4 while the overall mortality rate adjusted for age declined 6%. Death rates ...

In a world grappling with obesity and chronic disease, GLP-1 drugs like Ozempic are emerging as transformative game-changers. Initially designed for diabetes, these medications now promise ...

She queried if she was in danger, writing: “I’m freaking out. [I] saw a similar post but regarding Ozempic and these needles and loads of negative comments.” Customers have fallen seriously ...

Drugs like Ozempic could justify a deal. Hershey ‘now faces long-term headwinds from the expansion of GLP-1 drugs and heightened scrutiny on unhealthy food in the U.S.,’ TD Cowen says ...

The actress, 38, shared a candid post on Instagram on Thursday, Dec. 26, denouncing "Ozempic heroin chic," the modern version of "heroin chic" — a beauty trend from the 1990s that glorified ...

IIT Bombay has developed needle-free shock syringes for painless, safe drug delivery, offering hope for a future without injection-related trauma. Tested on rats, it outperformed traditional needles ...

Posting to his social media platform X (formerly Twitter), Musk shared an image of himself dressed as Santa Claus next to a Christmas tree alongside the caption “Ozempic Santa.” The post ...

Ozempic and Wegovy, made by Novo, are on track to become the world’s top-selling drugs by 2025. Yet in 2024, ‘Wegovy ...

In the caption, he wrote: "Ozempic Santa." In follow-up comments, he joked, "Like Cocaine Bear, but Santa and Ozempic! Technically, Mounjaro, but that doesn't have the same ring to it." ...